Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we wish to inform you that the Board of Directors of the Company ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Auro Laboratories Ltd's Board of Directors met on May 29, 2026 and approved the appointment of Mr. Nitesh Bohra as Chief Financial Officer and Key Managerial Personnel effective that date. The Board also appointed M/s B.L. Dasharda & Associates as Tax Auditors and Mr. Kuntal Pancholi as Internal Auditor for FY 2026-27, and re-appointed M/s Poddar & Co. as Cost Auditors. Additionally, the Board approved the audited financial results for Q4 and FY ended March 31, 2026, showing strong performance with Revenue from Operations growing 58.5% year-on-year to Rs 3,073.98 Lakhs, Profit Before Tax more than doubling to Rs 480.82 Lakhs, and Profit After Tax reaching Rs 353.29 Lakhs. Cash position improved significantly from Rs 0.03 Lakhs to Rs 136.69 Lakhs. The auditors issued an unmodified opinion on the financial results.
Strong financial performance with revenue and profit growth should be positive for shareholders. The appointment of a new CFO with over 20 years of experience and unchanged auditor opinion with unmodified report indicates stable governance, which could support investor confidence.